Deep brain stimulation provides a significant reduction in the symptoms of depression for a number of patients with a treatment-resistant form of the disorder.
Researchers report EEG technology has the ability to study activity of areas deep inside the brain, such as the thalamus and nucleus accumbens. The findings will help shed new light on disorders that affect these brain regions, such as Parkinson's disease and OCD.
Researchers have developed a neurofeedback system which allows Parkinson's patients to voluntarily control beta wave activity in the subthalamic nucleus.
MIT researchers have developed a new sensor that is able to track and monitor dopamine in the brain for up to a year. The sensor could be a useful tool in monitoring dopamine levels in those with Parkinson's disease, depression and other conditions linked to dopamine deficiencies.
Researchers report the adverse cognitive effects associated with DBS in Parkinson's patients are linked to a different neural pathway than the one responsible for the motor effects generated by the treatment.
Researchers have developed a new deep brain stimulation device that is able to use feedback from the brain to fine tune its signal. The device could help those with Parkinson's disease.
According to researchers, dopamine neurons may play a key role in the formation of episodic memory. The findings could help in the development of new treatments for neurodegenerative disorders that affect memory.
Researchers warn some deep brain stimulation devices may dysfunction and shut off during thunderstorms.